EVOFEM BIOSCIENC(EVFM) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Evofem Reports First Quarter 2025 Financial Results and Provides Business Update SAN DIEGO, CA, May 15, 2025 — Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM), today announced financial results for the first quarter ended March 31, 2025. "Quarterly fluctuations are normal for our business, which is why we focus on driving annual growth," said Saundra Pelletier, Evofem's CEO. "First quarter net sales were soft, as expected, due to the high level of PHEXXI stocking orders in the f ...